IgM in microbial infections: Taken for granted?

Immunology Letters

Volumn 125, Issue 2, 2009, Pages 79-85

  Racine, Rachael ^b   Winslow, Gary M ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

B 1 cell; IgM; Microbial infection

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY STRUCTURE; B LYMPHOCYTE; HUMAN; IMMUNOLOGICAL MEMORY; INFECTION; INNATE IMMUNITY; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; B-LYMPHOCYTE SUBSETS; BACTERIAL INFECTIONS; CYTIDINE DEAMINASE; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY; MICE; MICE, KNOCKOUT; VIRUS DISEASES;

EID: 68149178666     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.06.003     Document Type: Review

References (97)

1. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37 (2000) 1141-1149
2. Vieira P., and Rajewsky K. The half-lives of serum immunoglobulins in adult mice. Eur J Immunol 18 (1988) 313-316
3. Bendtzen K., Hansen M.B., Ross C., and Svenson M. High-avidity autoantibodies to cytokines. Immunol Today 19 (1998) 209-211
4. Notkins A.L. Polyreactivity of antibody molecules. Trends Immunol 25 (2004) 174-179
5. Cooper N.R., Nemerow G.R., and Mayes J.T. Methods to detect and quantitate complement activation. Springer Semin Immunopathol 6 (1983) 195-212
6. Satoh J., Prabhakar B.S., Haspel M.V., Ginsberg-Fellner F., and Notkins A.L. Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med 309 (1983) 217-220
7. Prabhakar B.S., Saegusa J., Onodera T., and Notkins A.L. Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol 133 (1984) 2815-2817
8. Dighiero G., Lymberi P., Mazie J.C., Rouyre S., Butler-Browne G.S., Whalen R.G., et al. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol 131 (1983) 2267-2272
9. Kantor A.B., and Herzenberg L.A. Origin of murine B cell lineages. Annu Rev Immunol 11 (1993) 501
10. Hardy R.R., and Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv Immunol 55 (1994) 297-339
11. Mond J.J., Vos Q., Lees A., and Snapper C.M. T cell independent antigens. Curr Opin Immunol 7 (1995) 349-354
12. Vos Q., Lees A., Wu Z.Q., Snapper C.M., and Mond J.J. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176 (2000) 154-170
13. Fehr T., Naim H.Y., Bachmann M.F., Ochsenbein A.F., Spielhofer P., Bucher E., et al. T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses. Nat Med 4 (1998) 945-948
14. Ochsenbein A.F., and Zinkernagel R.M. Natural antibodies and complement link innate and acquired immunity. Immunol Today 21 (2000) 624-630
15. Manivel V., Sahoo N.C., Salunke D.M., and Rao K.V. Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site. Immunity 13 (2000) 611-620
16. Wedemayer G.J., Patten P.A., Wang L.H., Schultz P.G., and Stevens R.C. Structural insights into the evolution of an antibody combining site. Science 276 (1997) 1665-1669
17. Yin J., Beuscher AEt, Andryski S.E., Stevens R.C., and Schultz P.G. Structural plasticity and the evolution of antibody affinity and specificity. J Mol Biol 330 (2003) 651-656
18. Coutinho A., Kazatchkine M.D., and Avrameas S. Natural autoantibodies. Curr Opin Immunol 7 (1995) 812-818
19. Haury M., Sundblad A., Grandien A., Barreau C., Coutinho A., and Nobrega A. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 27 (1997) 1557-1563
20. Mouthon L., Nobrega A., Nicolas N., Kaveri S.V., Barreau C., Coutinho A., et al. Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci USA 92 (1995) 3839-3843
21. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 12 (1991) 154-159
22. Casali P., and Schettino E.W. Structure and function of natural antibodies. Curr Top Microbiol Immunol 210 (1996) 167-179
23. Pereira P., Forni L., Larsson E.L., Cooper M., Heusser C., and Coutinho A. Autonomous activation of B and T cells in antigen-free mice. Eur J Immunol 16 (1986) 685-688
24. Zhou Z.H., Tzioufas A.G., and Notkins A.L. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 29 (2007) 219-228
25. Haas K.M., Poe J.C., Steeber D.A., and Tedder T.F. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23 (2005) 7-18
26. Ehrenstein M.R., O'Keefe T.L., Davies S.L., and Neuberger M.S. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 95 (1998) 10089-10093
27. Fearon D.T., and Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science 272 (1996) 50-54
28. Briles D.E., Nahm M., Schroer K., Davie J., Baker P., Kearney J., et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 153 (1981) 694-705
29. Gobet R., Cerny A., Ruedi E., Hengartner H., and Zinkernagel R.M. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. Exp Cell Biol 56 (1988) 175-180
30. Boes M., Prodeus A.P., Schmidt T., Carroll M.C., and Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188 (1998) 2381-2386
31. Baumgarth N., Herman O.C., Jager G.C., Brown L.E., Herzenberg L.A., and Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192 (2000) 271-280
32. Diamond M.S., Sitati E.M., Friend L.D., Higgs S., Shrestha B., and Engle M. A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 198 (2003) 1853-1862
33. Baumgarth N., Herman O.C., Jager G.C., Brown L., and Herzenberg L.A. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 96 (1999) 2250-2255
34. Alugupalli K.R., Gerstein R.M., Chen J., Szomolanyi-Tsuda E., Woodland R.T., and Leong J.M. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol 170 (2003) 3819-3827
35. Hsu M.C., Toellner K.M., Vinuesa C.G., and Maclennan I.C. B cell clones that sustain long-term plasmablast growth in T-independent extrafollicular antibody responses. Proc Natl Acad Sci USA 103 (2006) 5905-5910
36. Tornberg U.C., and Holmberg D. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures. EMBO J 14 (1995) 1680-1689
37. Kantor A.B., Merrill C.E., Herzenberg L.A., and Hillson J.L. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 158 (1997) 1175-1186
38. Zinkernagel R.M., LaMarre A., Ciurea A., Hunziker L., Ochsenbein A.F., McCoy K.D., et al. Neutralizing antiviral antibody responses. Adv Immunol 79 (2001) 1-53
39. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286 (1999) 2156-2159
40. Jayasekera J.P., Moseman E.A., and Carroll M.C. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol 81 (2007) 3487-3494
41. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
42. Harada Y., Muramatsu M., Shibata T., Honjo T., and Kuroda K. Unmutated immunoglobulin M can protect mice from death by influenza virus infection. J Exp Med 197 (2003) 1779-1785
43. Choi Y.S., and Baumgarth N. Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med 205 (2008) 3053-3064
44. Yang Y., Tung J.W., Ghosn E.E., and Herzenberg L.A. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci USA 104 (2007) 4542-4546
45. Szomolanyi-Tsuda E., Brien J.D., Dorgan J.E., Garcea R.L., Woodland R.T., and Welsh R.M. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology 280 (2001) 160-168
46. Bachmann M.F., Hengartner H., and Zinkernagel R.M. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?. Eur J Immunol 25 (1995) 3445-3451
47. Connolly S.E., and Benach J.L. The versatile roles of antibodies in Borrelia infections. Nat Rev Microbiol 3 (2005) 411-420
48. Barbour A.G. Antigenic variation of surface proteins of Borrelia species. Rev Infect Dis 10 Suppl. 2 (1988) S399-S402
49. Arimitsu Y., and Akama K. Characterization of protective antibodies produced in mice infected with Borrelia duttonii. Jpn J Med Sci Biol 26 (1973) 229-237
50. Yokota M., Morshed M.G., Nakazawa T., and Konishi H. Protective activity of Borrelia duttonii-specific immunoglobulin subclasses in mice. J Med Microbiol 46 (1997) 675-680
51. Connolly S.E., and Benach J.L. Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies. J Immunol 167 (2001) 3029-3032
52. Connolly S.E., Thanassi D.G., and Benach J.L. Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia. J Immunol 172 (2004) 1191-1197
53. Belperron A.A., Dailey C.M., and Bockenstedt L.K. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J Immunol 174 (2005) 5681-5686
54. Barbour A.G., and Bundoc V. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun 69 (2001) 1009-1015
55. Colombo M.J., and Alugupalli K.R. Complement factor H-binding protein, a putative virulence determinant of Borrelia hermsii, is an antigenic target for protective B1b lymphocytes. J Immunol 180 (2008) 4858-4864
56. Embers M.E., Ramamoorthy R., and Philipp M.T. Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease. Microbes Infect 6 (2004) 312-318
57. Barthold S.W., and Bockenstedt L.K. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun 61 (1993) 4696-4702
58. McKisic M.D., Redmond W.L., and Barthold S.W. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol 164 (2000) 6096-6099
59. Belperron A.A., and Bockenstedt L.K. Natural antibody affects survival of the spirochete Borrelia burgdorferi within feeding ticks. Infect Immun 69 (2001) 6456-6462
60. Belperron A.A., Dailey C.M., Booth C.J., and Bockenstedt L.K. Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection. Infect Immun 75 (2007) 3354-3360
61. Wuorimaa T., and Kayhty H. Current state of pneumococcal vaccines. Scand J Immunol 56 (2002) 111-129
62. Brown J.S., Hussell T., Gilliland S.M., Holden D.W., Paton J.C., Ehrenstein M.R., et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 99 (2002) 16969-16974
63. Engel P., Zhou L.J., Ord D.C., Sato S., Koller B., and Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3 (1995) 39-50
64. Rickert R.C., Rajewsky K., and Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376 (1995) 352-355
65. Casadevall A. Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun 71 (2003) 4225-4228
66. Li J.S., Chu F., Reilly A., and Winslow G.M. Antibodies highly effective in SCID mice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization. J Immunol 169 (2002) 1419-1425
67. Welsh O., Vera-Cabrera L., and Salinas-Carmona M.C. Mycetoma. Clin Dermatol 25 (2007) 195-202
68. Salinas-Carmona M.C. Nocardia brasiliensis: from microbe to human and experimental infections. Microbes Infect 2 (2000) 1373-1381
69. Salinas-Carmona M.C., and Perez-Rivera I. Humoral immunity through immunoglobulin M protects mice from an experimental actinomycetoma infection by Nocardia brasiliensis. Infect Immun 72 (2004) 5597-5604
70. Drabick J.J., Narayanan R.B., Williams J.C., Leduc J.W., and Nacy C.A. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Am J Med Sci 308 (1994) 83-87
71. Fulop M., Mastroeni P., Green M., and Titball R.W. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19 (2001) 4465-4472
72. Stenmark S., Lindgren H., Tarnvik A., and Sjostedt A. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica. Microb Pathog 35 (2003) 73-80
73. Kirimanjeswara G.S., Olmos S., Bakshi C.S., and Metzger D.W. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol Rev 225 (2008) 244-255
74. Rhinehart-Jones T.R., Fortier A.H., and Elkins K.L. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect Immun 62 (1994) 3129-3137
75. Elkins K.L., Rhinehart-Jones T., Nacy C.A., Winegar R.K., and Fortier A.H. T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect Immun 61 (1993) 823-829
76. Dreisbach V.C., Cowley S., and Elkins K.L. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon. Infect Immun 68 (2000) 1988-1996
77. Savitt A.G., Mena-Taboada P., Monsalve G., and Benach J.L. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy. Clin Vaccine Immunol 16 (2009) 414-422
78. Cole L.E., Yang Y., Elkins K.L., Fernandez E.T., Qureshi N., Shlomchik M.J., et al. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc Natl Acad Sci USA (2009)
79. Yager E., Bitsaktsis C., Nandi B., McBride J.W., and Winslow G. An essential role for humoral immunity during ehrlichia infection in immunocompetent mice. Infect Immun 73 (2005) 8009-8016
80. Li J.S., Yager E., Reilly M., Freeman C., Reddy G.R., Chu F.K., et al. Outer membrane protein specific monoclonal antibodies protect SCID Mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis. J Immunol 166 (2001) 1855-1862
81. Bitsaktsis C., Nandi B., Racine R., MacNamara K.C., and Winslow G. T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection. Infect Immun 75 (2007) 4933-4941
82. Racine R., Chatterjee M., and Winslow G.M. CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection. J Immunol 181 (2008) 1375-1385
83. Li J.S., and Winslow G. Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells. Infect Immun 71 (2003) 4229-4237 [see Commentary Infect Immun 4271:4225-4237]
84. Alugupalli K.R., Leong J.M., Woodland R.T., Muramatsu M., Honjo T., and Gerstein R.M. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 21 (2004) 379-390
85. Alugupalli K.R., Akira S., Lien E., and Leong J.M. MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses. J Immunol 178 (2007) 3740-3749
86. Seiler P., Kalinke U., Rulicke T., Bucher E.M., Bose C., Zinkernagel R.M., et al. Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice. J Virol 72 (1998) 2253-2258
87. Ochsenbein A.F., Pinschewer D.D., Odermatt B., Carroll M.C., Hengartner H., and Zinkernagel R.M. Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med 190 (1999) 1165-1174
88. Elkins K.L., Bosio C.M., and Rhinehart-Jones T.R. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect Immun 67 (1999) 6002-6007
89. Martin F., Oliver A.M., and Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14 (2001) 617-629
90. Fabrizio K., Groner A., Boes M., and Pirofski L.A. A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection. Clin Vaccine Immunol 14 (2007) 382-390
91. Burns T., Abadi M., and Pirofski L.A. Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide. Infect Immun 73 (2005) 4530-4538
92. Mukherjee J., Nussbaum G., Scharff M.D., and Casadevall A. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med 181 (1995) 405-409
93. Taborda C.P., and Casadevall A. Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J Immunol 166 (2001) 2100-2107
94. Paciorkowski N., Porte P., Shultz L., and Rajan T.V. B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites. J Exp Med 191 (2000) 731-735
95. Rajan B., Ramalingam T., and Rajan T.V. Critical role for IgM in host protection in experimental filarial infection. J Immunol 175 (2005) 1827-1833
96. Couper K.N., Roberts C.W., Brombacher F., Alexander J., and Johnson L.L. Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion. Infect Immun 73 (2005) 8060-8068
97. Couper K.N., Phillips R.S., Brombacher F., and Alexander J. Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection. Parasite Immunol 27 (2005) 171-180